{"doi":"10.1016/j.bmcl.2008.10.090","title":"Orally bioavailable prodrugs of a BCS class 2 molecule, an inhibitor of HIV-1 reverse transcriptase","abstract":null,"journal":"Bioorganic & Medicinal Chemistry Letters","year":2008,"id":662662,"datarank":0.38474240361923057,"base_score":2.5649493574615367,"endowment":2.5649493574615367,"self_citation_contribution":0.38474240361923057,"citation_network_contribution":0.0,"self_endowment_contribution":0.38474240361923057,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":12,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":633897,"name":"James P. Dunn","orcid":null,"position":1,"is_corresponding":false},{"id":1729991,"name":"J. Heather Hogg","orcid":null,"position":2,"is_corresponding":false},{"id":311146,"name":"Grace Lam","orcid":"0000-0001-7508-8666","position":3,"is_corresponding":false},{"id":1729993,"name":"Y. David Saito","orcid":null,"position":4,"is_corresponding":false},{"id":1729994,"name":"Tania M.P.C. Silva","orcid":null,"position":5,"is_corresponding":false},{"id":738748,"name":"Dimitrios Stefanidis","orcid":"0000-0002-2177-0763","position":6,"is_corresponding":false},{"id":1729995,"name":"Witold Woroniecki","orcid":null,"position":7,"is_corresponding":false},{"id":1729996,"name":"Eugenia Zhornisky","orcid":null,"position":8,"is_corresponding":false},{"id":1729997,"name":"Amy S. Zhou","orcid":null,"position":9,"is_corresponding":false},{"id":805263,"name":"Klaus Klumpp","orcid":"0000-0002-4829-3127","position":10,"is_corresponding":false},{"id":1729989,"name":"Todd R. Elworthy","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Orally bioavailable prodrugs of a BCS class 2 molecule, an inhibitor of HIV-1 reverse transcriptase","abstract":"The N-2 position of pyridazinone 1, a potent HIV-1 NNRTI that has limited aqueous solubility, was derivatized into a series of hydroxymethyl esters and carbonates as well as one phosphate. The derivatives served as prodrugs to effectively deliver 1 to rat plasma upon oral treatment at 50 mpk. Increases of 4.3- to 8.6-fold in 24-hour exposure of 1 (over that of parent) were observed while the prodrugs and the hydroxymethyl adduct 2 were undetectable.","is_dataset_classified":null,"base_score":2.5649493574615367,"endowment":2.5649493574615367,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"18993071","pmcid":null,"openalex_id":"https://openalex.org/W2040449416","authors":[],"funders":[],"total_grants":0,"fwci":1.1245,"citation_percentile":0.76107696,"influential_citations":0,"citation_trend":[{"year":2013,"count":1},{"year":2018,"count":2},{"year":2019,"count":1},{"year":2022,"count":1}],"oa_status":"closed","license":"https://www.elsevier.com/legal/tdmrep-license","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0960894X08013012?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0960894X08013012?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.bmcl.2008.10.090","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/18993071","host_type":"repository"}],"fields_of_study":["HIV/AIDS drug development and treatment","Drug Solubulity and Delivery Systems","Drug Transport and Resistance Mechanisms","Administration, Oral","Animals","Biological Availability","Carbonates","Chemistry, Pharmaceutical","Drug Design","Esters","HIV Reverse Transcriptase","HIV-1","Hydrogen-Ion Concentration","Models, Chemical","Prodrugs","Rats","Reverse Transcriptase Inhibitors","Solubility"],"mesh_terms":["Administration, Oral","Animals","Biological Availability","Carbonates","Chemistry, Pharmaceutical","Esters","Hydrogen-Ion Concentration","Models, Chemical","Prodrugs","Solubility","Drug Design","HIV-1","Reverse Transcriptase Inhibitors","Rats","HIV Reverse Transcriptase"],"keywords":["Prodrug","Chemistry","Hydroxymethyl","Bioavailability","Reverse transcriptase","Chemical synthesis","Pharmacokinetics","Reverse-transcriptase inhibitor","Oral administration","Enzyme inhibitor","Adduct","Stereochemistry","Pharmacology","Enzyme","In vitro","Biochemistry","Organic chemistry","RNA"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-12T16:48:19.926942Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}